Spyre Therapeutics
SYRE
#2075
Rank
ยฃ6.78 B
Marketcap
ยฃ71.45
Share price
-4.26%
Change (1 day)
285.64%
Change (1 year)

EPS for Spyre Therapeutics (SYRE)

EPS in 2026 (TTM): -ยฃ2.11

According to Spyre Therapeutics's latest financial reports the company's current EPS (TTM) is -ยฃ2.14. In 2025 the company made an earnings per share (EPS) of -ยฃ1.57 an increase over its 2024 EPS that were of -ยฃ2.85.

EPS history for Spyre Therapeutics from 2024 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ2.1134.21%
2025-ยฃ1.57-44.82%
2024-ยฃ2.85